GelStat working deal to expand product portfolio

PALM CITY, Fla. — GelStat on Monday announced its intent to acquire the rights to multiple products from Larry Gershman. The transaction is subject to the completion of standard due diligence and closing conditions and is expected to close within 45 days.

"This is an important milestone for GelStat as it is an extremely synergistic transaction that brings products and management depth to the company," stated Gerald Kieft, CEO GelStat. "It also validates GelStat's strategy to aggressively pursue acquisition targets that possess products with proven science, marketing or distribution," he said. "Additionally, it fits into the company's goal of becoming a global healthcare products company. Gershman's vast experience as a senior executive at top marketing firms and healthcare companies is exactly what GelStat needed to take the company to the next level. He has led many consumer product launches in the past that have generated tens of millions of dollars in revenue."

The products include an appetite suppressant chewing gum, an energy product, a joint pain lubricant and cartilage renewal product and a silver nano-particles anti-microbial and anti-acne face product.

Upon closing of the transaction, Gershman will assume the position as CEO and chairman GelStat. Kieft, the company's present CEO, will assume the position of CFO.

Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.

Poll

Poll

Which of the current U.S. Presidential hopefuls do you think would be best for your business?

Hillary Clinton

Jeb Bush

Donald Trump

Ted Cruz

Ben Carson

Scott Walker

Marco Rubio

Rand Paul

Chris Christie

Mike Huckabee

SPECIAL REPORTS

Pharmacy’s battle for recognition continues

Fifty years ago this summer, President Lyndon B. Johnson secured his place in history by signing into law the legislation that created Medicare and Medicaid. To commemorate the anniversary, Drug Store News has put together an exclusive report on the effect that Medicare and Medicaid have had on the retail pharmacy industry and how it has transformed the role of the pharmacist. more...

IN THIS ISSUE

In this issue, DSN profiles Rite Aid and how the company is achieving a vision to become a retail healthcare company that delivers a higher level of care to its communities; takes you on a tour of Sears; offers insight into millennial shoppers and more. Click here to view the issue.